BMPR1A and plasma cell myeloma: To investigate whether BMP inhibition had a direct effect on Wnt inhibitor expression in myeloma patients, we cultured human bone marrow stromal cells isolated from patients with myeloma or monoclonal gammopathy of unknown significance (MGUS) (characteristics in Supplementary Table 4), and treated them with either LDN or BMPR1a-FC.